DE69232975D1 - Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung - Google Patents

Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung

Info

Publication number
DE69232975D1
DE69232975D1 DE69232975T DE69232975T DE69232975D1 DE 69232975 D1 DE69232975 D1 DE 69232975D1 DE 69232975 T DE69232975 T DE 69232975T DE 69232975 T DE69232975 T DE 69232975T DE 69232975 D1 DE69232975 D1 DE 69232975D1
Authority
DE
Germany
Prior art keywords
dna sequences
corresponding dna
protein
human herpesvirus
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232975T
Other languages
English (en)
Other versions
DE69232975T2 (de
Inventor
Frank Neipel
Bernhard Fleckenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Publication of DE69232975D1 publication Critical patent/DE69232975D1/de
Application granted granted Critical
Publication of DE69232975T2 publication Critical patent/DE69232975T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16511Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/94Saccharomyces
    • Y10S435/942Saccharomyces cerevisiae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DE69232975T 1991-07-08 1992-06-15 Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung Expired - Lifetime DE69232975T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91111338 1991-07-08
EP91111338 1991-07-08

Publications (2)

Publication Number Publication Date
DE69232975D1 true DE69232975D1 (de) 2003-04-30
DE69232975T2 DE69232975T2 (de) 2004-03-04

Family

ID=8206915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232975T Expired - Lifetime DE69232975T2 (de) 1991-07-08 1992-06-15 Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung

Country Status (10)

Country Link
US (3) US5814475A (de)
EP (1) EP0524421B1 (de)
JP (1) JP3425164B2 (de)
AT (1) ATE235553T1 (de)
AU (1) AU666482B2 (de)
CA (1) CA2073282C (de)
DE (1) DE69232975T2 (de)
DK (1) DK0524421T3 (de)
ES (1) ES2194008T3 (de)
PT (1) PT524421E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4795993A (en) * 1992-07-31 1994-03-03 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for detecting human herpesvirus 6 strain z29
ATE240398T1 (de) 1997-07-11 2003-05-15 Fleckenstein Bernard Prof Dr Von kaposi-sarkom assoziiertem herpes-virus (kshv,hhv-8) kodiertes polypeptid und dessen verwendung in diagnostik und therapie
SE528319C2 (sv) * 2004-09-17 2006-10-17 Forskarpatent I Syd Ab Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn
CA2645134A1 (en) * 2006-03-08 2007-09-13 University Of Rochester Compositions and methods for detection and treatment of human herpesvirus (hhv)-6

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013536A1 (de) * 1989-05-04 1990-11-08 Univ Kansas Monoclonaler antikoerper fuer mit hhv-6 infizierte zellen und deren proteinmaterial sowie seine anwendungen
FR2651007B1 (fr) * 1989-08-18 1992-09-04 Pasteur Institut Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procede de diagnostic des infections a hhv6
DE4013526C2 (de) * 1990-04-27 1994-04-28 Rutenbeck Wilhelm Gmbh & Co Schaltungsanordnung zum Übertragen von Daten zwischen mehreren Geräten über eine Busleitung

Also Published As

Publication number Publication date
AU1945592A (en) 1993-01-14
EP0524421B1 (de) 2003-03-26
JP3425164B2 (ja) 2003-07-07
JPH06113858A (ja) 1994-04-26
US5814475A (en) 1998-09-29
PT524421E (pt) 2003-08-29
DK0524421T3 (da) 2003-07-21
US5827519A (en) 1998-10-27
US6174685B1 (en) 2001-01-16
ES2194008T3 (es) 2003-11-16
ATE235553T1 (de) 2003-04-15
DE69232975T2 (de) 2004-03-04
CA2073282A1 (en) 1993-01-09
AU666482B2 (en) 1996-02-15
CA2073282C (en) 2005-12-06
EP0524421A1 (de) 1993-01-27

Similar Documents

Publication Publication Date Title
DE59010367D1 (de) Muteine des menschlichen Erythropoetins, ihre Herstellung und ihre Verwendung
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
CA2045869A1 (en) Fusion proteins with immunoglobulin portions, the preparation and use thereof
EP0909814A3 (de) Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit
EP2141243A3 (de) Proteingerüste für Antikörpermimetika und andere Bindungsproteine
CA2124953A1 (en) Peptides related to prion proteins
CY1110505T1 (el) Ανθρωπινα αντισωματα dr4 και χρησεις αυτων
DE68929545D1 (de) Pollen Allergene
DE60042066D1 (de) Chimärische dr4 antikörper und ihre verwendung
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE69530380D1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
DE69232975D1 (de) Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung
DE69018755D1 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
EP1849800A3 (de) Moraxella catarrhalis-Proteine
FI971872A (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
SE9604439D0 (sv) New receptor
ATE130872T1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
WO1999061909A3 (en) Methods and compositions for the detection of human herpesvirus
DE59008523D1 (de) Verfahren zur Herstellung von Sulfonylharnstoff-Salzen und ihre Verwendung als Herbizide.
BR8902460A (pt) Processo para preparacao de hidrolisado de proteina de baixa imunogenicidade e antigenicidade,para uso enteral
EP1950302A3 (de) Streptokokken-Antigene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, , DE